Latest Breaking News On - Agonist use - Page 1 : comparemela.com

GLP1 receptor agonists do not up risk for complications after emergency surgery

Study reveals surge in use of weight loss-linked drugs in California health system

Skyrocketing demand for weight-loss drugs prompts calls for informed prescribing

The study reveals a significant increase in the usage of GLP-1 receptor agonists, particularly Ozempic and Trulicity, for weight management and Type 2 diabetes in the U.S. from 2014 to 2022. Amidst rapid growth and shortages, the paper calls for evidence-based decision-making to ensure stable medication supply and effective treatment.

Asthma may be common, but its impact is far from mild

Yang Xu, Director of Medical Affairs for Respiratory & Immunology at AstraZeneca UK, explores whether the UK over-relies on SABA inhalers, and how we can do better to improve asthma care and treatment.

GLP-1 Agonists can reduce risk of mortality, liver failure in patients with type 2 diabetes and cirrhosis

Taiwan: A recent population-based cohort study published in Clinical Gastroenterology and Hepatology has revealed multiple benefits of glucagon-like peptide-1 receptor agonist (GLP-1 RA) in patients.